Page last updated: 2024-11-05
vigabatrin and Liver Dysfunction
vigabatrin has been researched along with Liver Dysfunction in 2 studies
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| " More specifically, vigabatrin, which is a very useful and well tolerated new antiepileptic drug for refractory partial epilepsy, should be started at a low dosage of 0." | 4.79 | The new anticonvulsant drugs. Implications for avoidance of adverse effects. ( Krämer, G; Schmidt, D, 1994) |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Schmidt, D | 1 |
| Krämer, G | 1 |
| Kellermann, K | 1 |
| Soditt, V | 1 |
| Rambeck, B | 1 |
| Klinge, O | 1 |
Reviews
1 review available for vigabatrin and Liver Dysfunction
| Article | Year |
|---|---|
The new anticonvulsant drugs. Implications for avoidance of adverse effects.
Topics: Abnormalities, Drug-Induced; Anemia, Aplastic; Anticonvulsants; Chemical and Drug Induced Liver Inju | 1994 |
Other Studies
1 other study available for vigabatrin and Liver Dysfunction
| Article | Year |
|---|---|
Fatal hepatotoxicity in a child treated with vigabatrin.
Topics: Anticonvulsants; Child, Preschool; Epilepsy; Fatal Outcome; gamma-Aminobutyric Acid; Humans; Liver D | 1996 |